Optimale Datenaufnahme und -Auswertung Bei der Herzbinnenraumszintigraphie — Vergleich von First Pass (Mit Zeitaktivitätskurven und Repräsentativem Zyklus) und Aufnahmen Im Steady State

Author(s):  
H. W. Pabst ◽  
R. Bauer ◽  
E. Sauer
Keyword(s):  
1992 ◽  
Vol 71 (11) ◽  
pp. 1762-1767 ◽  
Author(s):  
M.L. Weaver ◽  
J.M. Tanzer ◽  
P.A. Kramer

We tested whether permucosal delivery of pilocarpine nitrate could be used to elicit significant salivary secretion. Pilocarpine (pKa 6.6 at 37°C) was applied as solutions (pHs 5.6, 6.6, 7.6; 15 mg/mL) to the buccal mucosa (2.8 cm2) of 6 anesthetized dogs. Saliva was collected continuously from cannulated submandibular and parotid ducts and blood sampled during and after drug administration. Plasma pilocarpine levels were determined by reversed-phase HPLC. Absorption rates were determined by use of data from separate zero-order intravenous infusions to the same dogs. Pilocarpine was buccally absorbed at a constant rate of 72.9 ± 38.5 μg/kg/h following its application at pH 7.6. At this pH of the drug solution, the time to appearance of pilocarpine in blood plasma was 0.31 ± 0.08 h, and the time to appearance of salivary flow was 0.86 ± 0.32 h. A threshold dose of 32.9 ± 7.5 ug/kg was required to induce secretion with the pH 7.6 drug, the steady-state plasma concentration was 28.9 ± 19.3 ng/mL, and the steady-state submandibular flow rate was 0.14 ± 0.11 mL/ min/gland pair. Salivary flow induction was symmetrical and reached levels as high as 0.35 mL/min/submandibular gland pair without apparent tachyphylaxis. Results at pHs 5.6, 6.6, and 7.6 were consistent with the hypothesis that pilocarpine is primarily absorbed as un-ionized drug. The data indicate that transmucosal delivery of pilocarpine, avoiding "first pass" hepatic loss, may hold promise for the treatment of xerostomia.


2004 ◽  
Vol 14 (3) ◽  
pp. 409-416 ◽  
Author(s):  
Peter Hunold ◽  
Stefan Maderwald ◽  
Holger Eggebrecht ◽  
Florian M. Vogt ◽  
J�rg Barkhausen

2009 ◽  
Vol 30 (4) ◽  
pp. 809-816 ◽  
Author(s):  
Claas P. Naehle ◽  
Andreas Müller ◽  
Winfried A. Willinek ◽  
Carsten Meyer ◽  
Tobias Hestermann ◽  
...  

1985 ◽  
Vol 6 (3) ◽  
pp. 341-343 ◽  
Author(s):  
John G. Wagner ◽  
Edward J. Antal ◽  
Alfred T. Elvin ◽  
William R. Gillespie ◽  
Evelyn A. Pratt ◽  
...  

2021 ◽  
Vol 23 (1) ◽  
Author(s):  
Alexander Isaak ◽  
Julian A. Luetkens ◽  
Anton Faron ◽  
Christoph Endler ◽  
Narine Mesropyan ◽  
...  

Abstract Background To evaluate a non-contrast respiratory- and electrocardiogram-gated 3D cardiovascular magnetic resonance angiography (CMRA) based on magnetization-prepared Dixon method (relaxation-enhanced angiography without contrast and triggering, REACT) for the assessment of the thoracic vasculature in congenital heart disease (CHD) patients. Methods 70 patients with CHD (mean 28 years, range: 10–65 years) were retrospectively identified in this single-center study. REACT-CMRA was applied with respiratory- and cardiac-gating. Image quality (IQ) of REACT-CMRA was compared to standard non-gated multi-phase first-pass-CMRA and respiratory- and electrocardiogram-gated steady-state-CMRA. IQ of different vessels of interest (ascending aorta, left pulmonary artery, left superior pulmonary vein, right coronary ostium, coronary sinus) was independently assessed by two readers on a five-point Likert scale. Measurements of vessel diameters were performed in predefined anatomic landmarks (ascending aorta, left pulmonary artery, left superior pulmonary vein). Both readers assessed artifacts and vascular abnormalities. Friedman test, chi-squared test, and Bland-Altman method were used for statistical analysis. Results Overall IQ score of REACT-CMRA was higher compared to first-pass-CMRA (3.5 ± 0.4 vs. 2.7 ± 0.4, P < 0.001) and did not differ from steady-state-CMRA (3.5 ± 0.4 vs. 3.5 ± 0.6, P = 0.99). Non-diagnostic IQ of the defined vessels of interest was observed less frequently on REACT-CMRA (1.7 %) compared to steady-state- (4.3 %, P = 0.046) or first-pass-CMRA (20.9 %, P < 0.001). Close agreements in vessel diameter measurements were observed between REACT-CMRA and steady-state-CMRA (e.g. ascending aorta, bias: 0.38 ± 1.0 mm, 95 % limits of agreement (LOA): − 1.62–2.38 mm). REACT-CMRA showed high intra- (bias: 0.04 ± 1.0 mm, 95 % LOA: − 1.9–2.0 mm) and interobserver (bias: 0.20 ± 1.1 mm, 95 % LOA: − 2.0–2.4 mm) agreements regarding vessel diameter measurements. Fat-water separation artifacts were observed in 11/70 (16 %) patients on REACT-CMRA but did not limit diagnostic utility. Six vascular abnormalities were detected on REACT-CMRA that were not seen on standard contrast-enhanced CMRA. Conclusions Non-contrast-enhanced cardiac-gated REACT-CMRA offers a high diagnostic quality for assessment of the thoracic vasculature in CHD patients.


2011 ◽  
Vol 46 (5) ◽  
pp. 307-316 ◽  
Author(s):  
Michele Anzidei ◽  
Alessandro Napoli ◽  
Fulvio Zaccagna ◽  
Beatrice Cavallo Marincola ◽  
Chiara Zini ◽  
...  

Radiology ◽  
2009 ◽  
Vol 251 (2) ◽  
pp. 457-466 ◽  
Author(s):  
Michele Anzidei ◽  
Alessandro Napoli ◽  
Beatrice Cavallo Marincola ◽  
Italo Nofroni ◽  
Daniel Geiger ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document